TKT and herpes simplex encephalitis: Furthermore, short-term ACV therapy (median: 8 days; range: 1–40 days) did not induce the emergence of ACVR-associated TK mutations in HSV isolates obtained from CSF samples of 4 HSE patients (Table 2).